Eight new products to Navamedic's portfolio
(Thomson Reuters ONE) -
Navamedic's wholly owned subsidiary Vitaflo Scandinavia has signed a
distribution agreement with UK based Vitaflo International Ltd (Nestlé) for
eight new nutritional products, expanding the portfolio to more than 65
pharmaceutical drugs and healthcare products.
The new products are all nutritional supplements used by patients with metabolic
disorders. Most of these patients need lifelong treatment in order to adjust
their metabolism.
The product expansion further strengthens Vitaflo's position in this segment and
supports a continued high sales growth for the company.
Despite sharing the same name and a common origin, Vitaflo International
(Nestlé) and Vitaflo Scandinavia are today two separate companies with different
owners.
Navamedic's subsidiary Vitaflo Scandinavia is a Nordic distributor of more than
65 pharmaceutical drugs and health care products from more than 20
manufacturers. The company saw a 29 per cent sales growth in 2011 followed by a
22 per cent sales growth in the first quarter 2012.
For further information, please call Olof Milveden, CEO, telephone
+46 733 463 736.
Navamedic ASA is a Norwegian pharmaceutical products company. Through its
subsidiary Vitaflo Scandinavia the Company is a distributor of a broad range of
nutrition and pharmaceutical products in the Nordic markets. Navamedic is
currently building up a generic pharmaceutical business for the Nordic, Dutch
and Belgian markets based on its partnership with Aspen Healthcare of South
Africa. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Navamedic ASA via Thomson Reuters ONE
[HUG#1617331]
Unternehmensinformation / Kurzprofil:
Datum: 05.06.2012 - 08:59 Uhr
Sprache: Deutsch
News-ID 152988
Anzahl Zeichen: 2436
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 183 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eight new products to Navamedic's portfolio"
steht unter der journalistisch-redaktionellen Verantwortung von
Navamedic ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
